Comparing Reduced Intensity Allo HCT to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome

Administered By

Awarded By

Contributors

Start/End

  • April 29, 2014 - June 30, 2020